Actinogen Medical (ASX:ACW) tackling Alzheimer's by inhibiting excess cortisol production in the brain

Latest Company News - Finance News Network

English - November 08, 2020 22:55 - 5 minutes - 1000 KB
Business News News Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: AMP (ASX:AMP) appoints new director

Next Episode: Karoon Energy (ASX:KAR) completes Bana acquisition

11 Nov 2020 - Actinogen Medical Limited (ASX:ACW) Managing Director and CEO Dr Bill Ketelbey provides an update on the company, discussing its lead drug candidate Xanamem, clinical trial roadmap and entitlement offer to raise up to $4.9m.